Therapy for sarcoidosis: evidence-based recommendations. - Wikidata - awgldk - TriplyDB

Therapy for sarcoidosis: evidence-based recommendations.

Therapy for sarcoidosis: evidence-based recommendations.

http://www.wikidata.org/entity/Q37965606

about

Rituximab in the treatment of refractory pulmonary sarcoidosis.Sarcoidosis - a clinically orientated review.A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis.Treatment of Sarcoidosis.Coexistence of pulmonary tuberculosis and sarcoidosis: a diagnostic dilemma.Bilateral Vocal Cord Carcinoma in a Sarcoidosis Patient during Infliximab Therapy.Peripheral neuropathies in rheumatic disease--a guide to diagnosis.Cardiac sarcoidosis: diagnosis and management.Cough in Sarcoidosis.Clinical management of pulmonary sarcoidosis.Advances in understanding the immunopathology of sarcoidosis and implications on therapy.Physical activity and training in sarcoidosis: review and experience-based recommendations.Efficacy of additional treatment with azathioprine in a patient with prednisolone-dependent gastric sarcoidosis Sarcoidosis in America. Analysis Based on Health Care Use.Sarcoidosis-associated fatigue: an often forgotten symptom--author reply.Sarcoidosis-associated fatigue: an often forgotten symptom.An atypical case of neurosarcoidosis presenting with neovascular glaucoma.

P2860

Q34204287-E6E76028-6A62-4964-9581-F6C65D0E6D8F Q34291268-31C6D3E7-6C41-490E-AA1D-427FF958727D Q34414996-E408639A-E4E1-435B-9721-FE95ACF3C682 Q34477003-49628C7C-286E-4D20-A4A8-BD5ABA2AEE72 Q34768158-0520F66B-8088-46B4-94BF-80B4BB8E72B9 Q36898628-B07881EE-5C34-4D98-93A5-DCC6E3D2770F Q38036106-3D7DF846-514B-46A5-9E8F-8D206FC263A9 Q38541252-049AC3C2-2CB0-44F1-A846-81ABF0BB137D Q38582886-E2C7A6D1-B5CC-449D-A834-2F65F2F2DF70 Q38766783-85730275-E370-4050-8685-F01C7B42EE36 Q38814035-D4A75A01-EAFD-4AAC-B61C-689BE1E02BC6 Q38934792-EB0286EB-2FD6-473B-B9B9-E9EDD794D379 Q39069307-D1B55140-DF8E-4CC2-A7DC-936511EA68FF Q39504304-15B3EC68-ECA0-4512-8D3B-79C8F27A54F2 Q43567782-EB842D33-1551-443A-85A6-03A355D2ABD0 Q45346872-553E5473-05FC-4A57-8534-41B553A98A48 Q55259386-0F37D99A-903B-4786-B32B-DBBE3314FC1E

P2860

Therapy for sarcoidosis: evidence-based recommendations.

http://www.wikidata.org/entity/Q37965606

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapy for sarcoidosis: evidence-based recommendations.

@en

Therapy for sarcoidosis: evidence-based recommendations.

@nl

type

label

Therapy for sarcoidosis: evidence-based recommendations.

@en

Therapy for sarcoidosis: evidence-based recommendations.

@nl

prefLabel

Therapy for sarcoidosis: evidence-based recommendations.

@en

Therapy for sarcoidosis: evidence-based recommendations.

@nl

P1433

Q37965606-FC104BB7-6979-4025-A1C6-9898FA4EEB49

P1476

Q37965606-74D26551-5222-4AA0-A388-C0AA6C9106DD

P2093

Q37965606-0D7B1301-B10E-4AD5-AE4F-FD4F3D6A1F45

Q37965606-E00A29A7-14A6-4996-8169-41F2DE8D16F8

P2860

Q37965606-090CB8FA-F4DC-4813-A269-9D41FAB04354

Q37965606-0BF87FC7-C5F2-4A93-AF91-762975990EB0

Q37965606-1387BF84-0619-43AD-B13B-E7FDDD8CA097

Q37965606-1967D128-D443-43AB-909C-4696990E2DD4

Q37965606-210A2BA3-9617-4AE4-984C-49B5224DA35F

Q37965606-22FF5E10-AFBC-48D4-816C-864AB889A8AB

Q37965606-2632D98E-E457-4EF1-9B9B-DEF1A2A5AB5E

Q37965606-263E097C-732C-41BA-890A-2930BA402E91

Q37965606-2A304A4C-0047-495C-A4DD-069DBF0AE2E2

Q37965606-2EF5FB77-E8C1-4561-9FED-854F9D0309ED

P304

Q37965606-9EC40261-27C4-4656-A521-A81DDA851057

P31

Q37965606-1A6AA736-78F3-4923-AAE9-51B85405CD7B

P356

Q37965606-4DA7404C-E05F-4218-B654-E0312CC7B1C0

P433

Q37965606-B79A7174-97AD-4230-AEA6-DC31BC365E8F

P478

Q37965606-A5E07DA6-5ACF-485A-B5F1-E86BAD3EB067

P577

Q37965606-905682D4-1535-4164-9383-03C515BA963F

P698

Q37965606-998DD76C-5A38-492D-899C-3BBF107C254F

P356

P1433

Expert Review of Clinical Immunology

P1476

Therapy for sarcoidosis: evidence-based recommendations.

@en

P2093

Hilario Nunes

http://www.w3.org/2001/XMLSchema#string

Robert P Baughman

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

Löfgren's syndrome: human leukocyte antigen strongly influences the disease course

Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil

The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital.

Clinical courses and prognoses of pulmonary sarcoidosis.

British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.

HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis.

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.

Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis.

P304

95-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECI.11.84

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22149344

http://www.w3.org/2001/XMLSchema#string